Table 3. Summary of adverse events.

	Fosaprepitant regimen (n=321)	Aprepitant regimen (n=323)	P value
Treatment-related adverse events	273 (85.05)	271 (83.9)	0.7444
Adverse reactions	83 (25.86)	88 (27.24)	0.7215
Serious adverse events	6 (1.87)	8 (2.48)	0.7882
Commonly reported AEs (≥1% of subjects)
Hiccup	27 (8.41)	23 (7.12)	0.5592
Constipation	23 (7.17)	26 (8.05)	0.7666
Decreased appetite/Anorexia	8 (2.49)	9 (2.79)	1.0000
Fatigue	7 (2.18)	9 (2.79)	0.8012
Dizziness	7 (2.18)	9 (2.79)	0.8012
Abdominal distention	6 (1.87)	9 (2.79)	0.6029
Vertigo	4 (1.25)	3 (0.93)	0.7244

AEs, adverse events.